KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Merck (MRK) Cash from Discontinued Operations (2020 - 2021)

Merck has reported Cash from Discontinued Operations over the past 2 years, most recently at 702000000.0 for Q4 2021.

Quarterly Cash from Discontinued Operations fell 236.31% to 702000000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 702000000.0 through Sep 2022, down 144.83% year-over-year, with the annual reading at 349000000.0 for FY2021, 85.37% down from the prior year.
Cash from Discontinued Operations was 702000000.0 for Q4 2021 at Merck, down from 638000000.0 in the prior quarter.
Over five years, Cash from Discontinued Operations peaked at 638000000.0 in Q3 2021 and troughed at 702000000.0 in Q4 2021.